AG007D5H

34661-75-1 | 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

Chemical structure of 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, CAS 34661-75-1
AG007D5H
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 34661-75-1
Catalog Number AG007D5H(AGN-PC-0JK7BH)
Chemical Name 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
EC Number 252-130-4
IUPAC Name 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione
InChI InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3
InChI Key ICMGLRUYEQNHPF-UHFFFAOYSA-N
MDL Number MFCD00133908
Molecular Formula C20H29N5O3
Molecular Weight 387.4760
NSC Number 310405
SMILES O(C)c1c(cccc1)N1CCN(CC1)CCCNc1n(C)c(=O)n(c(=O)c1)C
UNII A78GF17HJS
Synonyms
6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil, Ebrantil, urapidil, urapidil monohydrochloride, urapidil, 2,3-(14)C2-labeled, urapidil, 5-(14)C-labeled, urapidil, 34661-75-1, Ebrantil, Eupressyl, Mediatensyl, Uraprene, Urapidilum [INN-Latin], UNII-A78GF17HJS, NSC 310405, B-66256, C20H29N5O3, EINECS 252-130-4, BRN 0725782, A78GF17HJS, 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil, MLS003115907, 6-(3-(4-(o-Methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil, NCGC00016066-07, Ebrantil (TN), 6-((3-(4-(o-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyluracil, 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione, W-106718, Urapidilum, urapidil(jan), 6-[[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil, 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione, URACIL, 1,3-DIMETHYL-6-(3-(4-(o-METHOXYPHENYL)-1-PIPERAZINYL)PROPPYLAMINO)-, 1,3-dimethyl-6-[(3-{4-[2-(methyloxy)phenyl]piperazin-1-yl}propyl)amino]pyrimidine-2,4(1H,3H)-dione, 2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-, 2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-, 6-((3-(4-(2-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, CAS-64887-14-5, Urapidil [BAN:INN:JAN], Urapidil [INN:BAN:JAN], 6-[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propylamino]-1,3-dimethyluracil, Urapidil,(S), Spectrum_001360, Tocris-1772, SpecPlus_000683, Lopac-U-100, AC1L1KST, AC1Q6CKO, Prestwick0_000905, Prestwick1_000905, Prestwick2_000905, Prestwick3_000905, Spectrum2_001172, Spectrum3_001557, Spectrum4_000233, Spectrum5_001611, Urapidil (JP17/INN), DSSTox_CID_1425, 2,4(1H,3H)-dione, DSSTox_RID_76154, DSSTox_GSID_21425, Lopac0_001265, SCHEMBL48992, BSPBio_000750, BSPBio_003034, KBioGR_000925, KBioSS_001840, 5-25-15-00402 (Beilstein Handbook Reference), DivK1c_006779, SPECTRUM1503100, SPBio_001183, SPBio_002949, BPBio1_000826, CHEMBL279229, DTXSID9021425, CHEBI:32278, CTK4H2778, KBio1_001723, KBio2_001840, KBio2_004408, KBio2_006976, KBio3_002534, ICMGLRUYEQNHPF-UHFFFAOYSA-N, BCPP000025, HMS1922E11, BCP02494, HY-B0716, KS-000016PV, ZINC1544805, Tox21_110298, CCG-40329, MFCD00133908, NSC310405, STL454353, propylamino)-1,3-dimethylpyrimidine-, AKOS015896920, AC-8246, AN-6319, API0004555, DB12661, KS-5208, NSC-310405, VZ34075, NCGC00016066-01, NCGC00016066-02, NCGC00016066-03, NCGC00016066-04, NCGC00016066-05, NCGC00016066-06, NCGC00016066-08, NCGC00016066-09, NCGC00016066-10, NCGC00016066-11, NCGC00016066-16, NCGC00025290-01, NCGC00025290-02, NCGC00025290-03, NCGC00025290-04, NCGC00025290-05, NCGC00178336-01, NCGC00178336-02, 4CA-1304, 6-((3-(4- (2-methoxyphenyl)-1-piperazinyl)propyl)amino)- 1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, AK163085, CC-35548, H964, SMR001831470, BCP0726000257, SBI-0051232.P003, AB1009497, AX8156200, CAS-34661-75-1, LS-158663, AB00514699, CS-0009600, FT-0639207, U0085, 6-(3-(4-(2-methoxyphenyl)piperazin-1-yl), A17074, D01333, K-7882, AB00053328_10, AB00053328_11, 661U751, A822334, C-21481, L005359, I07-0038, BRD-K73196317-001-02-7, BRD-K73196317-003-03-1, BRD-K73196317-003-07-2, 6-[3-[4-(2-Methoxyphenyl)piperazinyl]propylamino]-1,3-dimethyluracil, Uracil,3-dimethyl-6-[3-[4-(o-methoxyphenyl)-1-piperazinyl]proppylamino]-, 6-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propylamino]-1,3-dimethylpyrimidine-2,4-dione, Uracil, 1,3-dimethyl-6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-, 2,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-, 2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl- (9CI), 2,4(1H,3H)-Pyrimidinedione,6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-, 6-((3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione #, 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propylamino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, uropidil, Urapidil HCl, Urapinil, Urapidil hydrochloride, AAV-huTNFR:Fc, TgAAV-TNFR:Fc, RAAV2-TNFR:Fc, urapidil monohydrochloride, TgAAC-94, D0K0VO, D0M8BE, RAAV-TNF, Targeted Genetics, urapidil, 5-(14)C-labeled, CID5639, urapidil, 2,3-(14)C2-labeled, AR-1L7976, C20-H29-N5-O3, CS-O-02543, 1710B, C015568, Gene therapy (rheumatoid arthritis), Targeted Genetics, 115787-68-3, 6639-43-6,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited